Hetian Tianli Shasheng Drug Development

Hetian Tianli Shasheng Drug Development is a specialized pharmaceutical company based in Xinjiang, China, focused on the research, cultivation, and industrialization of desert-based medicinal plants, specifically Cistanche tubulosa. The company is a key subsidiary of Sinopharm (China National Pharmaceutical Group) and is recognized for pioneering the modernization of Traditional Chinese Medicine through rigorous clinical validation. Its flagship product, Memoregain (Cistanche Total Glycosides Capsules), is a Class 2 New Chinese Medicine approved for the treatment of vascular dementia. The company operates a large-scale GAP-certified cultivation base in the Taklamakan Desert, integrating ecological restoration with high-tech pharmaceutical manufacturing. Its business model spans the entire value chain from botanical research and standardized farming to the production of neuroprotective therapeutics.